Shaquille O'Neal launched a national sleep‑apnea awareness drive on June 10, 2026, partnering with Eli Lilly’s Zepbound (tirzepatide) after learning his own moderate obstructive sleep apnea (OSA) was treatable.
What sparked the campaign?
The former NBA star disclosed that years of fatigue, loud snoring and poor focus were symptoms of OSA, not just a by‑product of his size. A routine check‑up revealed moderate‑to‑severe OSA, prompting his doctor to prescribe Zepbound. O'Neal said the diagnosis “clicked” and the medication helped him lose weight while improving his sleep quality.
How is Zepbound positioned?
Zepbound is marketed as the first prescription drug approved for moderate‑to‑severe OSA in adults with obesity, to be used alongside a reduced‑calorie diet and increased activity. Lilly estimates roughly 24 million U.S. adults live with OSA, yet 85 percent remain undiagnosed. The drug aims to close that gap by offering a pharmacologic option for patients who struggle with CPAP adherence.
What does the "Watch This" campaign include?
Lilly’s multi‑channel effort, named Watch This, builds around O'Neal’s personal story. It runs on broadcast TV, streaming services, digital ads and social media, plus live community events. In the ads, O'Neal narrates his own symptoms and the moment he decided to seek treatment, directing viewers to zepbound.lilly.com for self‑assessment tools and doctor‑referral information.
Why O'Neal’s involvement matters?
Lina Polimeni, senior vice president and chief marketing officer at Lilly, highlighted that O'Neal didn’t want to be a mere face on a poster. He wanted to speak honestly about his health, hoping his candor will push others from “just being tired” to consulting a physician. His stature in sports and pop culture gives the campaign instant credibility among men who may ignore sleep‑related issues.
What are the next steps for patients?
People suspecting OSA can now explore at‑home testing kits or schedule a doctor’s visit, according to Lilly’s website. The company stresses that treatment should combine medication, diet and exercise, echoing O'Neal’s own approach that led to modest weight loss alongside better sleep.
How does this fit into O'Neal’s broader health narrative?
Beyond basketball, O'Neal has become a vocal advocate for health awareness, from heart‑health initiatives to mental‑wellness talks. This partnership adds sleep health to his portfolio, reinforcing his role as a cultural icon who leverages personal experience to drive public‑health change.
What’s the timeline for the campaign?
The "Watch This" rollout began immediately after the June 10 announcement and will run through the rest of 2026, with periodic updates featuring O'Neal at community health fairs and live‑stream Q&A sessions. The goal is to boost diagnosis rates and encourage early treatment for millions of Americans.
What impact could this have on OSA treatment?
If even a fraction of the 24 million affected adults seek help because of O'Neal’s story, the public‑health impact could be significant. Early intervention often prevents complications like hypertension, heart disease and diabetes, aligning with Lilly’s broader mission to improve outcomes for obesity‑related conditions.